Y. Ueda

发表

Expression of thyroid transcription factor-1 in 16 human lung cancer cell lines.

A. Kubo, J. Fujita, S. Bandoh, 2003, Lung cancer.

Circulating Cytokeratin 8:Anti-Cytokeratin 8 Antibody Immune Complexes in Sera of Patients with Pulmonary Fibrosis

J. Fujita, Y. Ohtsuki, S. Hojo, 2000, Respiration.

The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions

N. Kadowaki, S. Bandoh, Y. Ueda, 2018, BMC Pulmonary Medicine.

Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.

N. Kadowaki, S. Bandoh, K. Kadota, 2017, Lung cancer.

Circulating bronchoepithelial cells expressing mRNA for surfactant protein A in patients with pulmonary fibrosis.

J. Fujita, S. Bandoh, S. Hojo, 2000, Respiratory medicine.

Mechanisms of the release of CYFRA21-1 in human lung cancer cell lines.

J. Fujita, S. Bandoh, Y. Ohtsuki, 2000, Lung cancer.

Increased intensity of lung infiltrates at the side of lung cancer in patients with lung cancer associated with pulmonary fibrosis.

J. Fujita, S. Bandoh, S. Hojo, 1999, Lung cancer.

A case of lung cancer associated with pneumoconiosis diagnosed by fluorine-18 fluorodeoxyglucose positron emission tomography

Y. Nishiyama, A. Kubo, J. Fujita, 2003, Annals of nuclear medicine.

Phase I trial of nedaplatin and S-1 in patients with advanced squamous cell lung cancer

N. Kadowaki, Y. Ueda, T. Ishii, 2020, Molecular and clinical oncology.

Expression of cytokeratin 19 mRNA in human lung cancer cell lines

J. Fujita, S. Bandoh, Y. Ohtsuki, 1999, International journal of cancer.

Expression of carcinoembryonic antigen in peripheral- or central-located small cell lung cancer: its clinical significance.

J. Fujita, S. Bandoh, T. Ishida, 2001, Japanese journal of clinical oncology.

Expression of cytokeratin 8 in lung cancer cell lines and measurement of serum cytokeratin 8 in lung cancer patients.

J. Fujita, S. Bandoh, T. Ishida, 2002, Lung cancer.

Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis

N. Kohno, J. Fujita, S. Bandoh, 2000, Annals of the rheumatic diseases.

A case of leptomeningeal metastasis from lung adenocarcinoma diagnosed by reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen.

J. Fujita, S. Bandoh, J. Takahara, 1998, Lung cancer.

Elevation of cytokeratin 19 fragment (CYFRA 21-1) in serum of patients with radiation pneumonitis: possible marker of epithelial cell damage.

A. Kubo, J. Fujita, S. Bandoh, 2004, Respiratory medicine.

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY).

S. Toyooka, K. Kiura, M. Takata, 2019, Chest.

Aberrant messenger RNA splicing of the cytokeratin 8 in lung cancer.

Fei Wu, A. Kubo, J. Fujita, 2003, Lung cancer.

Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non–Small‐Cell Lung Cancer Harboring EGFR Mutations: AfaBev‐CS Study Protocol

K. Kiura, I. Oze, M. Kodani, 2019, Clinical lung cancer.

Clinical features of patients with small cell lung cancer and idiopathic pulmonary fibrosis treated with chemotherapy or chemoradiotherapy

N. Kadowaki, H. Dobashi, T. Hida, 2020, Therapeutic advances in respiratory disease.

Uptake of fluorine-18-fluorodeoxyglucose in pulmonary Mycobacterium avium complex infection.

Y. Nishiyama, A. Kubo, J. Fujita, 2003, Internal medicine.

The point mutation in the promoter region and the single nucleotide polymorphism in exon 1 of the cytokeratin 19 gene in human lung cancer cell lines.

J. Fujita, S. Bandoh, T. Ishida, 2001, Lung cancer.

The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21‐1) in human lung cancer cell lines

Yasufumi Yamaji, Yu Yang, J. Fujita, 2001, International journal of cancer.

Binding of recombinant human cytokeratin 19 to laminin: a possible role in interaction between intermediate filament derived from epithelial cells and extracellular matrixes.

J. Fujita, S. Bandoh, T. Ishida, 2000, Cell structure and function.

Detection of large molecular weight cytokeratin 8 as carrier protein of CA19–9 in non-small-cell lung cancer cell lines

J. Fujita, S. Bandoh, Y. Ohtsuki, 1999, British Journal of Cancer.

Elevation of cytokeratin 19 fragment in patients with interstitial pneumonia associated with polymyositis/dermatomyositis.

J. Fujita, S. Bandoh, Y. Ohtsuki, 1999, The Journal of rheumatology.

Expression of nerve growth factor-induced clone B subfamily and pro-opiomelanocortin gene in lung cancer cell lines.

J. Fujita, S. Bandoh, Y. Yamaji, 1999, American journal of respiratory cell and molecular biology.

Full-Length Cytokeratin 8 Is Released and Circulates in Patients with Non-Small Cell Lung Cancer

A. Kubo, J. Fujita, S. Bandoh, 2008, Tumor Biology.

Primary lung cancer associated with polymyositis/dermatomyositis, with a review of the literature

J. Fujita, S. Bandoh, T. Ishida, 2001, Rheumatology International.

[A case of synchronous primary lung cancer with hamartoma].

J. Fujita, S. Bandoh, T. Ishida, 2003, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.